tm logo
Trademark Search
SCRIBE SICKLE CELL RECORD OF DAILY SYMPTOM BURDEN
SCRIBE SICKLE CELL RECORD OF DAILY SYMPTOM BURDEN
ABANDONED SECTION 36

on 17 Jul 2019

Last Applicant/ Owned by

GLOBAL BLOOD THERAPEUTICS INC.

171 Oyster Point Blvd., Suite 300South San Francisco, CA 94080

US

Serial Number

1859278 filed on 25th Sep 2017

Correspondent Address

Suite 2700, The Stack1133 Melville StVancouver

BRITISH COLUMBIA

CA

V6E4E5

SCRIBE SICKLE CELL RECORD OF DAILY SYMPTOM BURDEN

Trademark usage description

downloadable computer software used to provide computerized adaptive tests regarding patient symptoms and outcomes in clinical practice and research; Read More

Classification Information


Class [009]
Downloadable computer software used to provide computerized adaptive tests regarding patient symptoms and outcomes in clinical practice and research; downloadable scientific and medical data via the internet and downloadable questionnaires in connection with patient self-reported data to be used as tools for measurement of patient reported symptoms and other health outcomes in clinical practice and research


Classification kind code

11

Class [042]
Providing a database in the field of chronic disease information that allows the collection of data and information all for treatment diagnostic purposes and research and resources for measurement of patient report symptoms and other health outcomes in clinical practice and research


Classification kind code

11

Mark Details


Serial Number

1859278

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 17th Jul 2019
Abandoned - Section 36
Submitted for opposition 14
on 23rd Apr 2019
Default Notice Sent
Submitted for opposition 22
on 04th Oct 2018
Search Recorded
Submitted for opposition 20
on 04th Oct 2018
Examiner's First Report
Submitted for opposition 135
on 04th Jan 2018
Amendment to Application
Submitted for opposition 31
on 27th Sep 2017
Formalized
Submitted for opposition 1
on 26th Sep 2017
Created
Submitted for opposition 30
on 25th Sep 2017
Filed